CHENGDU, Chin, 20 maja 2023 r. /PRNewswire/ — 17 maja 2023 r. rekombinowana dwuskładnikowa szczepionka białkowa na COVID-19 (komórki Sf9) oraz rekombinowana trójskładnikowa szczepionka na COVID-19 oparta o białko trimerowe (komórki Sf9) opracowana przez WestVac Biopharma/ Centrum…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.